Skip to main content
. 2015 Jul 15;41(2):568–577. doi: 10.1038/npp.2015.184

Figure 2.

Figure 2

Effect of acute treatment with the NMDA channel blockers RS-ketamine (top, N=9) and AZD6765 (bottom, N=8) on list-DMS performance in cynomolgus monkeys. Results are presented as the group mean±SEM; * and ** indicate that performance differs from vehicle treatment at the p<0.05 and p<0.01 levels, respectively.